- Home
- PUMP vs IMTX Comparison
PUMP vs IMTX Comparison
Compare PUMP & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUMP
- IMTX
- Stock Information
- Founded
- PUMP 2007
- IMTX N/A
- Country
- PUMP United States
- IMTX Germany
- Employees
- PUMP N/A
- IMTX N/A
- Industry
- PUMP Oilfield Services/Equipment
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PUMP Energy
- IMTX Health Care
- Exchange
- PUMP Nasdaq
- IMTX Nasdaq
- Market Cap
- PUMP 550.9M
- IMTX 653.9M
- IPO Year
- PUMP 2017
- IMTX N/A
- Fundamental
- Price
- PUMP $6.56
- IMTX $6.00
- Analyst Decision
- PUMP Buy
- IMTX Strong Buy
- Analyst Count
- PUMP 5
- IMTX 4
- Target Price
- PUMP $9.75
- IMTX $14.67
- AVG Volume (30 Days)
- PUMP 2.0M
- IMTX 678.9K
- Earning Date
- PUMP 07-30-2025
- IMTX 08-12-2025
- Dividend Yield
- PUMP N/A
- IMTX N/A
- EPS Growth
- PUMP N/A
- IMTX N/A
- EPS
- PUMP N/A
- IMTX N/A
- Revenue
- PUMP $1,397,859,000.00
- IMTX $155,801,989.00
- Revenue This Year
- PUMP N/A
- IMTX N/A
- Revenue Next Year
- PUMP $9.57
- IMTX $1.92
- P/E Ratio
- PUMP N/A
- IMTX N/A
- Revenue Growth
- PUMP N/A
- IMTX 93.56
- 52 Week Low
- PUMP $4.61
- IMTX $3.30
- 52 Week High
- PUMP $11.17
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- PUMP 57.76
- IMTX 61.02
- Support Level
- PUMP $6.42
- IMTX $5.50
- Resistance Level
- PUMP $6.71
- IMTX $6.17
- Average True Range (ATR)
- PUMP 0.30
- IMTX 0.28
- MACD
- PUMP 0.02
- IMTX 0.02
- Stochastic Oscillator
- PUMP 76.79
- IMTX 81.38
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.